3-Bromo-1lambda6-benzothiophene-1,1-dione, 98%, 5g

4-(Pentyloxy)phthalonitrile, 95+%, 5g

6-Fluoropyrido[3,4-d]pyrimidin-4-ol, 95.0%, 250mg

Sodium hydroxide solution, ROTI® volume 0.1 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

1-Pyrazol-1-ylmethyl-1 H -pyrazole-3-carboxylic acid methyl ester, 250mg

(S)-(+)-Phenylsuccinic Acid>98.0%(T)(HPLC)1g

(S)-4-(Benzo[b]thiophen-3-yl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 97%, 1g

tert-Butyl k[1-(methylsulfonyl)piperidin-4-yl]methyllcarbamate, 95.0%, 1g

(S)-3-(4-fluorophenoxy)pyrrolidine, 98%, 250mg

2,2,2-Trifluoro-1-(4-methoxyphenyl)ethanamine, 95.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole, 97%, 1g

(2-{[2-(diethylamino)ethyl]amino}ethyl)diethylamine, 98%, 10g

Creatine phosphate disodium salt tetrahydr., min. 98%, for biochemistry, 10 g